What is the debt of Genmab A/S this year?
Genmab A/S has a debt level of -14,097 DKK this year.
Genmab A/S Debt 2025
Genmab A/S Debt
-14,097 DKK
Ticker
GMAB.CO
ISIN
DK0010272202
WKN
565131
In 2025, Genmab A/S's total debt was -14,097 DKK, a 51.65% change from the -9,296 DKK total debt recorded in the previous year.
Genmab A/S Aktienanalyse
What does Genmab A/S do?
Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.Debt Details
Understanding Genmab A/S's Debt Structure
Genmab A/S's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.
Year-to-Year Comparison
Analyzing Genmab A/S's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.
Impact on Investments
Investors pay close attention to Genmab A/S’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.
Interpreting Debt Fluctuations
Shifts in Genmab A/S’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.
Frequently Asked Questions about Genmab A/S stock
What was the debt of Genmab A/S compared to the previous year?
The debt of Genmab A/S has increased by 51.65% compared to the previous year increased.
What are the consequences of high debt for investors in Genmab A/S?
High debt can pose a risk for investors of Genmab A/S, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.
What are the consequences of low debt for investors of Genmab A/S?
Low debt means that Genmab A/S has a strong financial position and is able to fulfill its obligations without overburdening its finances.
How does an increase in debt from Genmab A/S affect the company?
An increase in debt of Genmab A/S can adversely affect the financial condition of the company and result in a higher burden on its finances.
How does a reduction of debt of Genmab A/S affect the company?
A reduction in debt of Genmab A/S can strengthen the company's financial position and improve its ability to meet its financial obligations.
What are some factors that influence the debt of Genmab A/S?
Some factors that can influence the debt of Genmab A/S include investments, acquisitions, operating costs, and revenue development.
Why are the debts of Genmab A/S so important for investors?
The debts of Genmab A/S are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.
What strategic measures can Genmab A/S take to change the debt?
To change the debt, Genmab A/S can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.
How much dividend does Genmab A/S pay?
Over the past 12 months, Genmab A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genmab A/S is expected to pay a dividend of 0 DKK.
What is the dividend yield of Genmab A/S?
The current dividend yield of Genmab A/S is .
When does Genmab A/S pay dividends?
Genmab A/S pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genmab A/S?
Genmab A/S paid dividends every year for the past 0 years.
What is the dividend of Genmab A/S?
For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genmab A/S located?
Genmab A/S is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genmab A/S kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genmab A/S from 1/22/2025 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 1/22/2025.
When did Genmab A/S pay the last dividend?
The last dividend was paid out on 1/22/2025.
What was the dividend of Genmab A/S in the year 2024?
In the year 2024, Genmab A/S distributed 0 DKK as dividends.
In which currency does Genmab A/S pay out the dividend?
The dividends of Genmab A/S are distributed in DKK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Genmab A/S stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Genmab A/S
Our stock analysis for Genmab A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genmab A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
